SPACInsider Logo
Delwinds Insurance (DWIN) Pre-Announces Redemptions, Listing Change
by Nicholas Alan Clayton on 2022-09-13 at 10:27am

Delwinds Insurance (NYSE:DWIN) announced this morning that it has received requests to redeem 99.5% of its shares and it is transferring its listing to the NYSE American exchange.

The SPAC noted that it had received requests for to redeem 10,991,407 as of its redemption deadline at 5:00 pm September 12. This came alongside news that inflation had once again exceeded estimates leading to an overall early morning stock rout and what looks to be a medium-term risk-off environment.

Recent weeks had seen some rays of sunshine in the redemptions department as Golden Path (NASDAQ:GPCO) made it to the finish line with its target MC Hologram with just 37.9% of shares redeemed and Riverview closed with Westrock Coffee (NASDAQ:WEST) with 73.5% of shares redeemed in the end. But on a whole, completed SPACs are still averaging 84.6% of shares redeemed on the year.

Delwinds prepared for this eventuality with a backstop worth up to $10 million as well as a $22.5 million convertible debenture and a $40 million committed equity facility announced at the same time as the transaction. The SPAC also announced yesterday that an institutional investor would purchase up to 3,000,000 shares in an FPA, however, this was intended to replace a portion of its backstop investors’ commitments. The deal does not include a minimum cash condition.

The parties announced their $369 million combination earlier this year on February 24. Minneapolis, Minnesota-based FOXO Technologies utilizes AI-driven bioinformatics and technologies to develop and commercialize epigenetic biomarkers of health and aging for the life insurance industry.

Delwinds shareholders are set to vote on the business combination at a special meeting at 9 am ET September 14. The parties expect to close the transaction on or around September 16 and the combined company’s shares are expected to trade under the symbol “FOXO” thereafter.

 

 

Recent Posts
by Kristi Marvin on 2023-01-28 at 1:59pm

Terms Tracker for the Week Ending January 27, 2022 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. We’re coming up on the end of January, the first month of the year, and to-date no new S-1s have been filed. Additionally, the number...

by Marlena Haddad on 2023-01-27 at 11:34am

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News: Circle spokesperson denies blaming SEC for failed deal, BuzzFeed CEO says AI-powered content will be part of core business, and FaZe Clan faces possible delisting Circle Spokesperson Denies Blaming SEC for Failed $9 Billion Deal...

by Nicholas Alan Clayton on 2023-01-27 at 10:00am

Health Sciences 2 (NASDAQ:HSAQ) announced that it closed its combination with Orchestra BioMed on January 26. HSAQ ahead of its vote pre-announced redemption figures of 1,597,888 shares equating to 67.7% redemptions, however, that’s still subject to change.  However, today it was noted that Orchestra BioMed is to receive $70 million in gross proceeds including $20...

by Kristi Marvin on 2023-01-27 at 7:33am

Carbon capture technology has long been talked about, and it is finally in operation with LanzaTech among the pioneers. Its plants are turning potential emissions into clothing, household goods and sustainable fuels. SPAC cash is now also an accelerant in this new process as the company announced a $1.7 billion combination with AMCI II last March. This week, we caught up with...

by Nicholas Alan Clayton on 2023-01-27 at 7:30am

In this series we’ll be examining successful SPAC deals from the past both in the terms and circumstances of their de-SPAC processes and how they have weathered the storms that have followed after their public listings with research from SPACInsider contributor Anthony Sozzi. Thirty months does not sound like that long, but it’s been a...

Privacy Policy|Terms Of Use
Copyright © 2022 SPACInsider, Inc. All Rights Reserved